12 November 2015 - SMC has announced forthcoming submissions for the following medicines: alirocumab (Praluent), atularen (Translarna), blinatumomab (Blincyto) & ceftolozane with tazobactam (Zerbaxa).

For more details, go to: https://maestrodatabase.com/admin/blog/blogpost/add/